<DOC>
	<DOCNO>NCT01152190</DOCNO>
	<brief_summary>The purpose trial evaluate effect tadalafil 5 milligram ( mg ) daily 8 week compare placebo prostatic blood perfusion men sign symptom Benign Prostatic Hyperplasia ( BPH ) , measure resistive index ( RI ) prostate transition zone .</brief_summary>
	<brief_title>A Study Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Inclusion Criteria Present benign prostatic hyperplasia Provide sign informed consent screen Agree use treatment Benign Prostatic Hyperplasia , Erectile Dysfunction Overactive Bladder ( include herbal treatment ) study Exclusion Criteria Have prostatic cancer treat cancer . Any condition may negatively influence transrectal ultrasound . Are treated heart disease drug call nitrate ( example , nitroglycerin ) . Any evidence moderate severe cardiac disease Have follow past 90 day : chest pain ( call unstable angina angina ) require treatment , heart attack also know myocardial infarction , heart bypass surgery ( call coronary artery bypass graft surgery ) , procedure open blood vessel heart know angioplasty stent placement ( percutaneous coronary intervention ) , positive cardiac stress test without effective cardiac intervention . Have high low blood pressure . Have uncontrolled diabetes . Have certain problem kidney , liver , nervous system .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>